Adalimumab added to Methotrexate and intra-articular glucocorticoid increases remission rates at one year in early, DMARD-naïve patients with rheumatoid arthritis - An investigator-initiated randomized, controlled, double-blinded study.
Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › fagfællebedømt
Adalimumab added to Methotrexate and intra-articular glucocorticoid increases remission rates at one year in early, DMARD-naïve patients with rheumatoid arthritis - An investigator-initiated randomized, controlled, double-blinded study.
Originalsprog | Engelsk |
---|---|
Tidsskrift | Arthritis & Rheumatism |
Vol/bind | 63 |
Udgave nummer | 10 (suppl.) |
Sider (fra-til) | S147 |
Antal sider | 1 |
ISSN | 0004-3591 |
Status | Udgivet - 2011 |
ID: 40159956